PCSA
NASDAQ · Pharmaceuticals
Processa Pharmaceuticals Inc
$1.89
-0.07 (-3.57%)
Open$1.88
Previous Close$1.96
Day High$1.94
Day Low$1.87
52W High$14.24
52W Low$1.67
Volume—
Avg Volume30.7K
Market Cap5.31M
P/E Ratio—
EPS$-5.77
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+1,852.4% upside
Current
$1.89
$1.89
Target
$36.90
$36.90
$23.79
$36.90 avg
$41.20
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 2.71M | 2.46M | 2.10M |
| Net Income | 319.8K | 302.9K | 327.4K |
| Profit Margin | 11.8% | 12.3% | 15.6% |
| EBITDA | 521.3K | 563.7K | 431.6K |
| Free Cash Flow | 364.0K | 435.1K | 285.7K |
| Rev Growth | +2.4% | +0.4% | +18.3% |
| Debt/Equity | 0.28 | 0.35 | 0.28 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,164.89 | +1.04% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.47 | -0.19% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $149.50 | +1.79% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.74 | +0.29% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.62 | -0.70% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $71.33 | -0.10% | 11.5 | 30.15B |